Telepatia raises $33M from Andreessen Horowitz to deploy AI healthcare across Latin America

Colombian AI Startup Secures Major Funding to Transform Regional Healthcare

Telepatia, an AI clinical assistant startup built specifically for Latin American healthcare systems, has raised $33 million in a Series A round led by Andreessen Horowitz 1

1

. The funding brings the company's total capital to $42 million, with backing from notable investors including Palantir CTO Shyam Sankar, Rappi founder Simón Borrero, and Nubank founder David Vélez 1

1

. The Colombian company has set an ambitious target: reaching half of Latin America's 1.9 million doctors by the end of 2027 1

1

.

Personal Tragedy Drives Innovation in AI Healthcare

The origin of Telepatia stems from a devastating personal loss. CEO Nicolás Abad's father, a physician known as "Telepatia" for his diagnostic intuition, died at age 58 in late 2022 from a preventable drug interaction between a hiccup treatment and sleep medication 1

1

. His death occurred just days before ChatGPT's release, which ushered in AI capable of catching such risks 2

2

. "This is the product that would have saved my father as a patient, and that he would have loved as a doctor," Abad said 1

1

. The physician had spent years reading medical papers about his own illness, yet the fatal interaction went undetected 1

1

.

How the AI-Powered Healthcare Tool Works

The AI-native clinical platform transcribes consultations in real time, reviews medical records, flags potential errors, and makes live suggestions based on medical literature and clinical guidelines 1

1

. Abad describes it as "a second brain for the doctor" 1

1

. The platform combines AI-driven documentation, clinical decision support, and a growing suite of AI healthcare employees including AI doctors, nurses, and auditors, all integrated across hospital systems and trained on clinical guidelines, peer-reviewed literature, and local institutional protocols 2

2

.

Addressing Latin America's Clinician Shortage

Latin America faces severe healthcare workforce challenges that make it an ideal market for AI healthcare solutions. Brazil and Colombia each have roughly 2.4 to 2.5 doctors per 1,000 people, representing 43% fewer physicians than OECD countries on average 1

1

2

2

. Colombia has just 1.5 nurses per 1,000 people compared to the OECD's 9.5, reflecting 65% fewer nurses per capita 1

1

2

2

. Doctors and nurses in the region spend 40% to 70% of their time on healthcare documentation and administrative tasks rather than direct patient care 1

1

.

Measurable Impact Across Hospital Systems

Since launching in July 2024, Telepatia has deployed across 25+ hospital systems in Brazil, Colombia, Mexico, Chile, and Argentina, reaching 14 million patients 1

1

2

2

. At Hospital Mater Dei in Brazil, physicians use the tool an average of eight hours a day and recover 1.7 hours daily, according to company data 1

1

2

2

. Protocol adherence has risen from 84% to 99% after deployment 2

2

. The platform has already prevented 60,000 medical errors in real time, allowing physicians to adjust course immediately 2

2

. José Henrique Dias Salvador, CEO of Mater Dei, noted: "The real test of any clinical tool is whether doctors actually use it. Our physicians use Telepatia eight hours a day. We've never seen adoption like that" 2

2

.

Strategic Market Positioning and Future Expansion

Daisy Wolf, a partner at Andreessen Horowitz, stated: "We just clearly saw them as the winner. We believe healthcare is going to be the industry most transformed by AI" 1

1

. For Andreessen Horowitz, which has backed US ambient documentation startups Abridge AI and Ambience Healthcare, Telepatia represents one of its largest AI healthcare investments outside the US 1

1

. The top 100 health institutions in Latin America employ 50% of physicians, meaning a single platform can achieve outsized distribution once it breaks into top systems 2

2

. The company plans to deepen Latin American operations before expanding to India, Africa, and Southeast Asia, where similar physician shortages and documentation burdens exist at even larger scale 1

1

. Abad has stated his goal is to win the first Nobel Prize in Medicine awarded to a Latin American since 1984, noting that recent Nobel Prizes in Physics and Chemistry have gone to breakthroughs powered by AI 2

2

.